Related references
Note: Only part of the references are listed.Accuracy of chitotriosidase activity and CCL18 concentration in assessing type I Gaucher disease severity. A systematic review with meta-analysis of individual participant data
Tatiana Raskovalova et al.
HAEMATOLOGICA (2021)
Plasma chitotriosidase activity versus plasma glucosylsphingosine in wide spectrum of Gaucher disease phenotypes - A statistical insight
Anna Tyki-Szymanska et al.
MOLECULAR GENETICS AND METABOLISM (2018)
Modelling long-term evolution of chitotriosidase in non-neuronopathic Gaucher disease
Cristina Drugan et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2017)
Impact of Imiglucerase Supply Shortage on Clinical and Laboratory Parameters in Norrbottnian Patients with Gaucher Disease Type 3
Maciej Machaczka et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2015)
Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy
L. van Dussen et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2014)
Modeling changes in biomarkers in Gaucher disease patients receiving enzyme replacement therapy using a pathophysiological model
Marie Vigan et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
Evaluation of Spanish Gaucher disease patients after a 6-month imiglucerase shortage
Pilar Giraldo et al.
BLOOD CELLS MOLECULES AND DISEASES (2011)
Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies
Johannes M. F. G. Aerts et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2011)
Force Majeure: Therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease
Carla E. M. Hollak et al.
BLOOD CELLS MOLECULES AND DISEASES (2010)
Lysosomal storage disease 1 - Phenotype, diagnosis, and treatment of Gaucher's disease
Gregory A. Grabowski
LANCET (2008)
Monitoring of Gaucher patients with a novel chitotriosidase assay
Aricha Schoonhoven et al.
CLINICA CHIMICA ACTA (2007)
Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease
PB Deegan et al.
BLOOD CELLS MOLECULES AND DISEASES (2005)
Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases
JMFG Aerts et al.
ACTA PAEDIATRICA (2005)
Changes in serum chitotriosidase activity with cessation of replacement enzyme (cerebrosidase) administration in Gaucher disease
B Czartoryska et al.
CLINICAL BIOCHEMISTRY (2000)
Share Paper
